PNC Financial Services Group’s HilleVax HLVX Stock Holding History

PNC Financial Services Group’s Portfolio HLVX Stock Details HLVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,446	Closed	-$2.88K	–	5140
2025 Q2	$2.88K	Sell	1,446 -714	-33%	-$1.31K	﹤0.01%	4306
2025 Q1	$3.13K	Sell	2,160 -151	-7%	-$279	﹤0.01%	4211
2024 Q4	$4.78K	Buy	2,311 +2,296	+15,307%	+$4.31K	﹤0.01%	4046
2024 Q3	$26	Hold	15	–	–	﹤0.01%	4758
2024 Q2	$217	Buy	+15	New	+$206	﹤0.01%	4656

PNC Financial Services Group's HLVX Position: Q3 2025 in Review

PNC Financial Services Group sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 1,446 shares — an estimated $2.88K sold.

PNC Financial Services Group first reported a position in HLVX in Q2 2024 and held it in 5 quarters. The position peaked at $4.78K in Q4 2024. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

PNC Financial Services Group reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
PNC Financial Services Group sold 1,446 HilleVax shares in Q3 2025, an estimated $2.88K.
PNC Financial Services Group first reported a position in HilleVax in Q2 2024 and held it in 5 quarters.
PNC Financial Services Group's HilleVax position peaked at $4.78K in Q4 2024.
1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on PNC Financial Services Group's 13F filing for Q3 2025, filed 7 Nov 2025.